Detection of a novel antigen for Crohn's disease

CONCLUSIONS: Our results suggested that anti-CABP could be used as a serological marker to assist the diagnosis of CD.CLINICAL TRIAL REGISTRATION: This trial is registered with clinical trial registration unique identifier ChiCTR2000037094.PMID:34487462 | DOI:10.1080/00365521.2021.1973088

Source: Scandinavian Journal of Gastroenterology - September 6, 2021 Category: Gastroenterology Authors: Yarong Wei Tingting Chen Wu Yang Huihui Li Chen Fang Qiuyuan Liu Yonghao Chen Qiao Mei Source Type: research